Population | Frequency of lipid marker monitoring (times/month)a | P-value | ||
---|---|---|---|---|
N | Mean | SD | ||
Eligible patients | 3464 | 0.078 | 0.184 | – |
Primary analysis population (PS matched) | ||||
With atypical antipsychotic | 185 | 0.051 | 0.123 | 0.080 |
Without atypical antipsychotic | 185 | 0.076 | 0.147 |